Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
BPC-157 is currently classified as an FDA Category 2 bulk drug substance, reflecting both its research interest and its regulatory status as a compound under active scientific scrutiny
Doctors prescribed this medicine to patients who suffer from vitamin B12 deficiency, peripheral neuropathy, megaloblastic anemia, and neurological disorders
Depending on the prescribed treatment, peptide therapy may be administered subcutaneously, intramuscularly, orally, or intravenously
While its intended to be given intramuscularly, epinephrine will also work if given subcutaneously
US$ 21.62
US$ 20.05
US$ 23.75
US$ 21.44
:max_bytes(150000):strip_icc()/GettyImages-758312269-e8f09e45f7614626a9526273bb03c1fc.jpg)